EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›WLKP

WLKP

Westlake Chemical Partners LP

Next earnings Aug 3, 2026 (before open) · consensus $0.43 EPS, $548M rev

Last earnings -0.4% on 2026-05-05

Hold
$22.66
▲ +0.58%
$22.66▲ +12.65%
over 1Y
L $17.13EODHDH $23.33
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+0.6%
1W+0.4%
1M-0.4%
3M+6.5%
YTD+24.7%
1Y+12.6%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Hold
Quality
B
Valuation
Overvalued
Filings
Flagged
Hold
Conviction
Horizon
Long (>12mo)
12-mo target
$•••
Street · 7 analysts
Buy

Fee-based ethylene MLP with Westlake take-or-pay floor; stable cash flow but eroding margins and IDR drag cap upside.

Revenue $1.17B · FY2025

The read

Middling fundamentals and a rich price (~48% above fair value) leave little margin of safety — a wait-and-see.

WLKP is a structurally unusual security: its sole revenue-generating asset is a 22.8% LP interest in OpCo, with Westlake holding the remaining 77.2% plus the general partner and incentive distribution rights (IDRs). The MD&A makes clear that the Ethylene Sales Agreement is a long-term, fee-based contract under which Westlake is obligated to take 95% of OpCo's budgeted ethylene production at a fixed $0.10/lb margin, with a Buyer Deficiency Fee if it under-takes. That contractual floor is the entire investment case — it converts a commodity petrochemical business into something closer to a toll road, which is why FY2025 revenue of $1.17B (+2.7% YoY) and a 27.4% operating margin held up despite a brutal ethylene cycle.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$1.21B$1.59B$1.19B$1.14B$1.17B
Gross profit$442M$377M$387M$419M$348M
Operating income$411M$348M$358M$390M$320M
Net income$82.5M$64.2M$54.3M$62.4M$48.7M
Diluted EPS—————
Net margin6.8%4.0%4.6%5.5%4.2%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$754M
EV / EBITDA1.7
EV / Sales0.6
EV / FCF3.7
P / FCF4.0
PEG (trailing)—
Earnings yield6.1%
FCF yield25.2%

Quality & risk

ROIC (est.)—
Free cash flow$202M
Total debt—
Net cash$44.3M
Piotroski F-Score4/8

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+0.0%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Recent disclosure tone has skewed negative — read the flagged items.
  1. 10-Q Quarterly report2026-05-06

    Q1 2026 10-Q filed; reflects continued margin pressure on the ethylene MLP

  2. 8-K Earnings results2026-05-05

    Q1 2026 earnings released; reaffirms steady ethylene MLP distribution model

  3. 8-K Officer / director change2026-04-20

    Executive officer change announced via 5.02; no operational impact disclosed

  4. S-3 Shelf registration (potential raise)2026-03-04

    FY2025: revenue +2.7% to $1.17B but net income -22%, op income -18% YoY

  5. 10-K Annual report2026-03-04

    FY2025: revenue +2.7% to $1.17B but net income -22%, op income -18% YoY

  6. 8-K Earnings results2026-02-24

    Q4/FY2025 results: net income fell 22% YoY to $48.7M on weaker margins

  7. 8-K Officer / director change2026-02-23

    Officer/director change reported with limited additional disclosure

  8. 10-Q Quarterly report2025-10-31

    Q3 2025 10-Q: ethylene volumes/margins underpin minimum-commitment revenue

  9. 8-K Material agreement2025-10-30

    Q3 2025 earnings plus a new material agreement (item 1.01) disclosed

Recent filings

all on EDGAR ↗
3Period ending 2026-06-152026-06-15open ↗10-QPeriod ending 2026-03-312026-05-06open ↗8-KPeriod ending 2026-05-052026-05-05open ↗8-KPeriod ending 2026-04-202026-04-20open ↗EFFECTFiling2026-03-11open ↗CORRESPFiling2026-03-09open ↗UPLOADFiling2026-03-09open ↗S-3Filing2026-03-04open ↗10-KPeriod ending 2025-12-312026-03-04open ↗8-KPeriod ending 2026-02-242026-02-24open ↗8-KPeriod ending 2026-02-182026-02-23open ↗SCHEDULE 13GFiling2026-02-17open ↗

Quality score

B
ValueGrowthProfitHealthMom.
ValueA
GrowthF
ProfitabilityB+
Financial healthA-
Momentum—
  • ✓Revenue growing year-over-year
  • ✓Profitable (positive net income)
  • ✗Net margin above 10%
  • ✓P/E below 25

Fair value est.

$11.87

Overvalued -48% vs price

cheapfair valueexpensive

Modified Graham: EPS $1.47 × (8.5 + 1.5 × 0.0% growth) × 0.95 quality = 8.1× multiple. An estimate, not a price target.

Revenue
$1.17B
+2.7% YoY
Net margin
4.2%
ROE
—
P/E
15.4

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$1.17B+2.7%
Net income$48.7M-21.9%
Gross profit$348M-17.0%
Operating income$320M-18.2%
Diluted EPS$1.47
Cash & equivalents$44.3M-24.1%
Total assets$1.26B-2.4%
Total liabilities$454M-1.0%
Gross: 29.8%Op.: 27.4%

Frequently asked

Is Westlake Chemical Partners LP (WLKP) a buy?
WLKP currently carries a Hold rating with 3/5 conviction, derived from its latest SEC filings. Fee-based ethylene MLP with Westlake take-or-pay floor; stable cash flow but eroding margins and IDR drag cap upside.
What is WLKP's fair value?
A Modified-Graham model based on WLKP's SEC fundamentals estimates a fair value of about $11.87. It is an estimate from reported earnings, not a price target.
Is WLKP overvalued or undervalued?
Against a Modified-Graham fair-value estimate, WLKP currently appears overvalued relative to its SEC-grounded earnings power.
What is Westlake Chemical Partners LP's quality score?
WLKP scores 70.49999999999999/100 (grade B) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001604665, latest 10-Q filed 2026-05-06) · EODHD · analysis by claude-code · as of 6/25/2026, 3:00:17 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2025-08-27
Gilson Jean-Marc
President and CEO
Buy95.29 @ $21.25$2.02K
2025-08-21
Gilson Jean-Marc
President and CEO
Buy1.25K @ $22.02$27.5K
2025-08-20
Gilson Jean-Marc
President and CEO
Buy1.25K @ $21.86$27.3K
2025-08-15
Gilson Jean-Marc
President and CEO
Buy4.70K @ $21.84$103K
2025-08-07
WOELFEL RANDY
Director
Exercise4.88K
2025-08-07
WOELFEL RANDY
Director
Disposed (D)4.88K @ $21.96$107K
2025-08-07
Friel Lisa A.
Director
Exercise4.88K
2025-08-07
Friel Lisa A.
Director
Disposed (D)2.44K @ $21.96$53.6K
2025-08-07
FINLEY G STEPHEN
Director
Exercise4.88K
2025-05-29
Gilson Jean-Marc
President and CEO
Buy93.73 @ $22.20$2.08K
2025-05-29
Chao James
Senior Chairman
Sell3.70K @ $22.10$81.8K
2025-05-28
Chao James
Senior Chairman
Sell4.60K @ $22.10$102K

Dividends

Quarterly
Yield (TTM)
8.3%
Annual / share
$1.88
Last ex-date
2026-05-14
Last amount
$0.47
ex 2026-05-14paid 2026-06-01$0.47
ex 2026-02-06paid 2026-02-23$0.47
ex 2025-11-10paid 2025-11-26$0.47
ex 2025-08-12paid 2025-08-27$0.47
ex 2025-05-13paid 2025-05-29$0.47
ex 2025-02-07paid 2025-02-25$0.47

Source: EODHD. Yield = trailing-12-month dividends ÷ price.

Earnings history

beat/miss · move
2026-05-05Miss -8.8% est▼ -0.44%8-K ↗
2026-02-24Miss -4.3% est▲ +3.95%8-K ↗
2025-10-30Miss -6.4% est▲ 0.00%8-K ↗
2025-08-05Miss -11.7% est▲ +0.96%8-K ↗
2025-05-02—▼ -2.23%8-K ↗
2025-02-24—▲ +0.83%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
Westlake Chemical Partners LP Q1 2026 Earnings Call SummaryBullish
finance.yahoo.com· 2026-05-05
Westlake Chemical (WLKP) Q1 2026 Earnings TranscriptBullish
finance.yahoo.com· 2026-05-05
Here are the major earnings before the open TuesdayBullish
seekingalpha.com· 2026-05-04
Westlake Chemical Partners Announce First Quarter 2026 Conference CallBullish
finance.yahoo.com· 2026-04-21
Westlake Chemical Partners names Jonathan Baksht CFOBullish
seekingalpha.com· 2026-04-21
Westlake Chemical Partners Appoints Jonathan H. Baksht as Senior Vice President and Chief Financial OfficerBullish
finance.yahoo.com· 2026-04-20

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score70 vs 67
Revenue growth2.7% vs 7.1%
Net margin4.2% vs 10.5%
Return on equity— vs 12.3%
P/E15.4 vs 25.5

News sentiment

EODHD · 2d
Bearish
-0.08
vs typical · 3 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.